|
|
|
Volumn 26, Issue 2 SUPPL. 7, 1999, Pages 3-21
|
|
The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (3 AMINOPROPYLAMINO)ETHANETHIOL;
4 HYDROPEROXYCYCLOPHOSPHAMIDE;
AMIFOSTINE;
BLEOMYCIN;
CARBOPLATIN;
CHLORMETHINE;
CISPLATIN;
CYTARABINE;
DOCETAXEL;
ETOPOSIDE;
FLUOROURACIL;
HEMATOPORPHYRIN;
IDARUBICIN;
MAFOSFAMIDE;
MELPHALAN;
MITOMYCIN C;
MITOXANTRONE;
PACLITAXEL;
VINBLASTINE;
VINCRISTINE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL PROTECTION;
CYTOTOXICITY;
DEPHOSPHORYLATION;
DRUG EFFECT;
HUMAN;
HUMAN TISSUE;
INTESTINE CRYPT;
MALIGNANT NEOPLASTIC DISEASE;
MEMBRANE BINDING;
PRIORITY JOURNAL;
STEM CELL;
XENOGRAFT;
AMIFOSTINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CYTOPROTECTION;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
MERCAPTOETHYLAMINES;
NEOPLASMS;
NEOPLASMS, EXPERIMENTAL;
PRODRUGS;
PROTECTIVE AGENTS;
RADIATION-PROTECTIVE AGENTS;
TUMOR CELLS, CULTURED;
|
|
EID: 0033038974
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (137)
|
|
References (99)
|
